Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we describe an optimized direct reprogramming system for melanocytes and a high-efficiency, concentrated virus packaging system that ensures smooth direct reprogramming.

Abstract

The loss of function of melanocytes leads to vitiligo, which seriously affects the physical and mental health of the affected individuals. Presently, there is no effective long-term treatment for vitiligo. Therefore, it is imperative to develop a convenient and effective treatment for vitiligo. Regenerative medicine technology for direct reprogramming of skin cells into melanocytes seems to be a promising novel treatment of vitiligo. This involves the direct reprogramming of the patient's skin cells into functional melanocytes to help ameliorate the loss of melanocytes in patients with vitiligo. However, this method needs to be first tested on mice. Although direct reprogramming is widely used, there is no clear protocol for direct reprogramming into melanocytes. Moreover, the number of available transcription factors is overwhelming.

Here, a concentrated lentivirus packaging system protocol is presented to produce transcription factors selected for reprogramming skin cells to melanocytes, including Sox10, Mitf, Pax3, Sox2, Sox9, and Snai2. Mouse embryonic fibroblasts (MEFs) were infected with the concentrated lentivirus for all these transcription factors for the direct reprogramming of the MEFs into induced melanocytes (iMels) in vitro. Furthermore, these transcription factors were screened, and the system was optimized for direct reprogramming to melanocytes. The expression of the characteristic markers of melanin in iMels at the gene or protein level was significantly increased. These results suggest that direct reprogramming of fibroblasts to melanocytes could be a successful new therapeutic strategy for vitiligo and confirm the mechanism of melanocyte development, which will provide the basis for further direct reprogramming of fibroblasts into melanocytes in vivo.

Introduction

Vitiligo is a skin disease that seriously affects the physical and mental health of the affected individuals. For various reasons, including metabolic abnormalities, oxidative stress, generation of inflammatory mediators, cell detachment, and autoimmune response, the functional melanocytes are lost, and the secretion of melanin is stopped, leading to the development of vitiligo1,2. This condition occurs widely and is particularly problematic on the face. The main treatment is the systemic use of corticosteroids and immunomodulators. Phototherapy can be used for systemic or local diseases, and there are surgica....

Protocol

This work was approved by the Laboratory Animal Management and Use Committee at Jiangsu University (UJS-IACUC-AP--20190305010). The experiments were performed in strict accordance with the standards established by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC International). There were no experiments involving humans, so this work did not need approval from the human research ethics committee. Refer to the Table of Materials for details about reagents.

Representative Results

This article includes the protocols of a concentrated lentivirus packaging system to produce lentivirus of transcription factors for direct reprogramming of fibroblasts to melanocytes and protocols for screening for transcription factors and direct reprogramming of melanocytes from MEFs.

The success of concentrated lentivirus production was evaluated by observing the fluorescence intensity of GFP (Figure 1A) or by flow cytometry (Figure 1B

Discussion

The quality of the virus is crucial for the success of direct reprogramming to melanocytes in this protocol. The method of packaging and concentrating viruses in this protocol is simple and easy to repeat and does not rely on any other auxiliary concentrated reagent. This protocol can be followed successfully in most laboratories. To ensure the quality of the concentrated virus, the following points need special attention. One is the cell status of HEK-293T. Although HEK-293T cells are immortalized cells, the cells used .......

Acknowledgements

This study was partially supported by grants from the National Natural Science Foundation of China (82070638 and 81770621) and the Natural Science Foundation of Jiangsu Province (BK20180281).

....

Materials

NameCompanyCatalog NumberComments
0.05% Trypsin-EDTAGibco25300-062Stored at -20 °C
0.45 μM filterMilliporeSLHVR33RB
5 mL polystyrene round bottom tubeFalcon352052
95%/100% ethanolLANBAO210106Stored at RT
AdenineSigmaA2786Stock concentration 40 mg/mL
Final concentration 24 µg/mL
Alexa Fluor 555 Goat anti-Mouse IgG2aInvitrogenA21137Dilution of 1:500 to use
Antibiotics(Pen/Strep)Gibco15140-122Stored at -20 °C
Anti-TRP1/TYRP1 AntibodyMilliporeMABC592Host/Isotype: Mouse IgG2a
Species reactivity: Mouse/Human
Dilution of 1:200 to use
Anti-TRP2/DCT AntibodyAbcamab74073Host/Isotype: Rabbit IgG
Species reactivity: Mouse/Human Dilution of 1:200 to use
CHIR99021Stemgent04-0004Stock concentration 10 mM
Final concentration 3 μM
Cholera toxinSigmaC8052Stock concentration 0.3 mg/mL
Final concentration 20 pM
Cy3 Goat anti-Rabbit IgG (H+L)Jackson Immunoresearch111-165-144Dilution of 1:500 to use
DMEM (High glucose)HyCloneSH30243.01Stored at 4 °C
DMSO SigmaD2650Stored at RT
FBSGibco10270-106Stored at -20 °C
Heat-inactivated before use
GelatinSigmaG9391Stored at RT
GFP-PURO plasmids (Mitf, Sox10, Pax3, Sox2, Sox9 and Snai2)Hanheng Biological Technology Co., Ltd.pHBLPm003198 pHBLPm001143 pHBLPm002968 pHBLPm002981 pHBLPm004348 pHBLPm000325Stored at -20 °C
HematoxylinAbcamab220365Stored at RT
Human EDN3American-Peptide88-5-10AStock concentration 100 μM
Final concentration 0.1 μM
HydrocortisoneSigmaH0888Stock concentration 100 µg/mL
Final concentration 0.5 µg/mL
L-DOPASigmaD9628Stored at RT
Lipofectamine 2000Invitrogen11668-019Transfection reagent, stored at 4 °C
Masson-Fontana staining kitSolarbioG2032Stored at 4 °C
Neutral balsamSolarbioG8590Stored at 4 °C
ParaformaldehydeSigmaP6148Stored at RT
PBS (-)GibcoC10010500BTStored at RT
Phorbol 12-myristate 13-acetate (TPA)SigmaP8139Stock concentration 1 mM
Final concentration 200 nM
PolybreneSigmaH9268cationic polymeric transfection reagent; Stock concentration 8 μg/µL
Final concentration 4 ng/µL
PuromycinGibcoA11138-03Stored at -20 °C
Recombinant human bFGFInvitrogen13256-029Stock concentration 4 μg/mL
Final concentration 10 ng/mL
Recombinant human insulinSigma I3536Stock concentration 10 mg/mL
Final concentration 5 µg/mL
Recombinant human SCFR&D255-SC-010Stock concentration 200 μg/mL
Final concentration 100 ng/mL
RPMI-1640Gibco11875-093Stored at 4 °C
XyleneSigma1330-20-7Stored at RT

References

  1. Ezzedine, K., Eleftheriadou, V., Whitton, M., van Geel, N. Vitiligo. Lancet. 386 (9988), 74-84 (2015).
  2. Picardo, M., et al. Vitiligo. Nature Reviews. Disease Primers. 1, 15011 (2015).
  3. Speeckaert, R., van Geel, N.

Explore More Articles

Direct ReprogrammingMelanocytesTranscription FactorsMITFSOX10PAX3Lentivirus ProductionHEK 293T CellsVirus Concentration

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved